Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation

Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation

The optimal antithrombotic treatment in patients receiving oral anticoagulation undergoing percutaneous coronary intervention (PCI) has been a field of intensive research. Although triple antithrombotic therapy had been, until lately, the strategy of choice, recent evidence points to the superiority...

Full description

Bibliographic Details
Main Authors:	Despoina-Rafailia Benetou, Panayotis K Vlachakis, Charalampos Varlamos, Dimitrios Alexopoulos
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2021-05-01
Series:	US Cardiology Review
Online Access:	https://www.uscjournal.com/articleindex/usc.2020.31

Similar Items

Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
by: Despoina-Rafailia Benetou, et al.
Published: (2021-10-01)

Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021-06-01)

Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021-05-01)

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020-11-01)

Delayed percutaneous coronary intervention for an extensive iatrogenic left main coronary artery dissection: a case report
by: Charalampos Varlamos, et al.
Published: (2022-12-01)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
by: Jarosław Zalewski, et al.
Published: (2016-11-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Antithrombotic therapy after percutaneous revascularization in patients on chronic oral anticoagulation treatment
by: Juan M. Ruiz-Nodar, et al.
Published: (2019-02-01)

Antithrombotic Regimens in Patients With Percutaneous Coronary Intervention Whom an Anticoagulant Is Indicated: A Systematic Review and Network Meta-Analysis
by: Wipharak Bunmark, et al.
Published: (2018-11-01)

Ultrasound-Guided Femoral Vascular Access for Percutaneous Coronary and Structural Interventions
by: Iosif Xenogiannis, et al.
Published: (2023-06-01)

HOW EFFECTIVE ARE ANTITHROMBOTIC THERAPIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION
Published: (2016-03-01)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010-09-01)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021-09-01)

Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.
by: Hideki Kitahara, et al.
Published: (2022-01-01)

The Usefulness of Intracoronary Imaging in Patients with ST-Segment Elevation Myocardial Infarction
by: Grigoris V. Karamasis, et al.
Published: (2023-09-01)

Use of Optical Coherence Tomography in MI with Non-obstructive Coronary Arteries
by: Grigoris Karamasis, et al.
Published: (2022-05-01)

Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Felice Gragnano, et al.
Published: (2023-12-01)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
by: Mattia Galli, et al.
Published: (2023-03-01)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
by: Wenbin Lu, et al.
Published: (2021-10-01)

Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention
Published: (2023-01-01)

Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.
by: Hideki Kitahara, et al.
Published: (2023-01-01)

Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry.
by: Dawid L Staudacher, et al.
Published: (2015-01-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Leonardo De Luca, et al.
Published: (2022-01-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
by: Caylie M. Poirier, PharmD, ACPR, et al.
Published: (2023-11-01)

Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective
by: Antonio Greco, et al.
Published: (2023-01-01)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022-02-01)

Use of cangrelor in percutaneous coronary interventions: a “new” weapon in the antithrombotic therapeutic armamentarium
by: José Luis Ferreiro, et al.
Published: (2020-11-01)

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome
by: Corinne Frere, et al.
Published: (2019-01-01)

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting
by: Sergio Buccheri, et al.
Published: (2019-12-01)

A network meta-analysis of the antithrombotic strategies in patients with atrial fibrillation and percutaneous coronary interventions: Focus on bleeding
by: Kyriakos Dimitriadis, et al.
Published: (2023-09-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention
by: Eric A. Secemsky, et al.
Published: (2016-10-01)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention.
by: Jiesuck Park, et al.
Published: (2020-01-01)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
by: Anne-Marije Hulshof, et al.
Published: (2021-12-01)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
by: Shujuan Zhao, et al.
Published: (2021-06-01)

Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020-12-01)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
by: Marek Koziński, et al.
Published: (2020-06-01)

Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
by: Jiesuck Park, et al.
Published: (2021-04-01)

Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention
by: V. А. Ryagina, et al.
Published: (2023-01-01)